Statistical analysis of IHC scores for each marker revealed significantly higher expression of all four markers CD44, CD90, CD133, and EpCAM in tumor tissues compared to non-tumor tissues (P < 0.05), as shown in Figure 1B. This evidence concerns the gene CD44 and neoplasm.